Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer

PURPOSE: To identify the optimal dosing strategy for fluorescence guided surgery in patients with head and neck squamous cell carcinoma, we conducted a dose ranging study evaluating the anti-epidermal growth factor receptor (EGFR) therapeutic antibody, panitumumab, that was fluorescently labeled wit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Imaging Biol
Main Authors: Nishio, Naoki, van den Berg, Nynke S., van Keulen, Stan, Martin, Brock A., Fakurnejad, Shayan, Zhou, Quan, Lu, Guolan, Chirita, Stefania U., Kaplan, Michael J., Divi, Vasu, Colevas, Alexander D., Rosenthal, Eben L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7017887/
https://ncbi.nlm.nih.gov/pubmed/31054001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11307-019-01358-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados